CR2-fH Fusion Protein TT30

A recombinant, chimeric human fusion protein consisting of the iC3b/C3d-binding region of human complement receptor type 2 (CR2/CD21) linked to the alternative complement pathway (ACP) inhibitory domain of human factor H (fH) (CR2-fH), with potential complement system inhibiting activity. Via its C3 binding domain, TT30 selectively binds to complement activated cell surfaces and via its fH binding domain regulates ACP activity. This suppresses excessive complement activity and may result in an inhibition of ACP-mediated hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) red blood cells (RBCs) as well as preventing ACP-induced tissue damage. Factor H is a key regulator in the activation of ACP. (NCI Thesaurus)

YOU MAY ALSO LIKE

CR2 wt Allele

Human CR2 wild-type allele is located in the vicinity of 1q32 and is approximately 36 kb in length. This allele, which encodes…

CR2 Gene

This gene plays a role in the innate immune response.

CR1 wt Allele

Human CR1 wild-type allele is located in the vicinity of 1q32 and is approximately 146 kb in length. This allele, which encodes…

CR1 Gene

This gene is involved in the complement activation pathway.

CQS

A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called chloroquinoxaline sulfonamide.

CPT1C wt Allele

Human CPT1C wild-type allele is located in the vicinity of 19q13.33 and is approximately 23 kb in length. This allele, which encodes…